Tag: Therapy & Procedures: Misc.
SGLT2 Inhibitors Linked to Reduced Risk for Serious Renal Events
Data from three countries showed drop in serious renal events with sodium-glucose cotransporter 2 inhibitors
NT-proBNP Does Not Improve Evaluation of Syncope in the ED
Serum NT-proBNP concentrations were generally higher in patients with 30-day serious adverse events
PFS Prolonged With Continuous Dabrafenib, Trametinib in Melanoma
Median PFS longer with continuous versus intermittent treatment, but overall survival similar
USPSTF: Behavioral Interventions Likely Prevent Tobacco Use
Primary care-feasible behavioral interventions have moderate net benefit for school-aged children
Adding High-Dose Chloroquine Not Advised for Severe COVID-19
High-dose versus low-dose group had higher lethality until day 13, more instances of QTc interval >500 ms
Expert Panel: There Are No Proven Drug Treatments for COVID-19
Whenever possible, drugs should be given to COVID-19 patients as part of a clinical trial
Physicians Report Expanding Use of Off-Label COVID-19 Treatments
Hydroxychloroquine usage increasing rapidly, although plasma from recovered patients perceived as more effective
Convalescent Plasma Treatment Promising in Severe COVID-19
One dose of CP with neutralizing antibodies can reduce viral load, tends to improve clinical symptoms
Test for COVID-19 Antibodies Approved by FDA
Test checks for protective antibodies in a finger prick of blood
Phone-Based Therapy Beneficial for Depression in Parkinson Disease
Telephone CBT outperformed treatment-as-usual on all depression, anxiety, quality-of-life measures
